Clopidogrel therapy did not yield better outcomes for babies with cyanotic congenital heart disease and a systemic-to-pulmonary-artery shunt compared with placebo and conventional treatment, a study showed. Rates of death, overall bleeding and severe bleeding were similar for both clopidogel and placebo groups, researchers reported in the New England Journal of Medicine.

Full Story:

Related Summaries